Business Context and Reporting Period
This Form 8-K was filed by Griffin-American Healthcare REIT IV, Inc. on February 11, 2021. The filing reports a corporate governance event regarding the renewal of the company's advisory agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual event and does not contain financial performance data.
Material Changes
On February 11, 2021, the registrant entered into an additional mutual consent to renew its advisory agreement with Griffin-American Healthcare REIT IV Holdings, LP (the operating partnership) and Griffin-American Healthcare REIT IV Advisor, LLC (the advisor). This follows a series of previous renewals dating back to the original agreement signed on February 16, 2016.
Outlook and Management Commentary
The renewed advisory agreement is set to terminate on February 16, 2022, unless earlier terminated in accordance with its terms. The agreement may be renewed for an additional one-year term upon written mutual consent of the parties. No specific guidance, risks, or unusual items were disclosed in this filing.
Key Facts for Investors to Verify
- The advisory agreement has been renewed for a one-year term ending February 16, 2022.
- The registrant is an emerging growth company.
- No securities are currently registered under Section 12(b) of the Exchange Act.
- The filing contains no financial data; investors should refer to periodic reports (10-K/10-Q) for financial metrics.